Literature DB >> 24747836

The utilization of oropharyngeal intratracheal PAMP administration and bronchoalveolar lavage to evaluate the host immune response in mice.

Irving C Allen1.   

Abstract

The host immune response to pathogens is a complex biological process. The majority of in vivo studies classically employed to characterize host-pathogen interactions take advantage of intraperitoneal injections of select bacteria or pathogen associated molecular patterns (PAMPs) in mice. While these techniques have yielded tremendous data associated with infectious disease pathobiology, intraperitoneal injection models are not always appropriate for host-pathogen interaction studies in the lung. Utilizing an acute lung inflammation model in mice, it is possible to conduct a high resolution analysis of the host innate immune response utilizing lipopolysaccharide (LPS). Here, we describe the methods to administer LPS using nonsurgical oropharyngeal intratracheal administration, monitor clinical parameters associated with disease pathogenesis, and utilize bronchoalveolar lavage fluid to evaluate the host immune response. The techniques that are described are widely applicable for studying the host innate immune response to a diverse range of PAMPs and pathogens. Likewise, with minor modifications, these techniques can also be applied in studies evaluating allergic airway inflammation and in pharmacological applications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24747836      PMCID: PMC4161211          DOI: 10.3791/51391

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

1.  Variable airway responsiveness to inhaled lipopolysaccharide.

Authors:  J N Kline; J D Cowden; G W Hunninghake; B C Schutte; J L Watt; C L Wohlford-Lenane; L S Powers; M P Jones; D A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

2.  Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome.

Authors:  Chahnaz Kebaier; Robin R Chamberland; Irving C Allen; Xi Gao; Peter M Broglie; Joshua D Hall; Corey Jania; Claire M Doerschuk; Stephen L Tilley; Joseph A Duncan
Journal:  J Infect Dis       Date:  2012-01-25       Impact factor: 5.226

3.  Expression and function of NPSR1/GPRA in the lung before and after induction of asthma-like disease.

Authors:  Irving C Allen; Amy J Pace; Leigh A Jania; Julie G Ledford; Anne M Latour; John N Snouwaert; Virginie Bernier; Rino Stocco; Alex G Therien; Beverly H Koller
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-07-07       Impact factor: 5.464

4.  An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals.

Authors:  Gustavo Matute-Bello; Gregory Downey; Bethany B Moore; Steve D Groshong; Michael A Matthay; Arthur S Slutsky; Wolfgang M Kuebler
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05       Impact factor: 6.914

5.  Non-surgical intratracheal instillation of mice with analysis of lungs and lung draining lymph nodes by flow cytometry.

Authors:  Manira Rayamajhi; Elizabeth F Redente; Tracy V Condon; Mercedes Gonzalez-Juarrero; David W H Riches; Laurel L Lenz
Journal:  J Vis Exp       Date:  2011-05-02       Impact factor: 1.355

6.  The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice.

Authors:  V L Cressman; E M Hicks; W K Funkhouser; D C Backlund; B H Koller
Journal:  Am J Respir Cell Mol Biol       Date:  1998-12       Impact factor: 6.914

7.  Analysis of NLRP3 in the development of allergic airway disease in mice.

Authors:  Irving C Allen; Corey M Jania; Justin E Wilson; Erin M Tekeppe; Xiaoyang Hua; Willie J Brickey; Mildred Kwan; Beverly H Koller; Stephen L Tilley; Jenny P-Y Ting
Journal:  J Immunol       Date:  2012-02-08       Impact factor: 5.422

8.  Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology.

Authors:  Christine Egger; Catherine Cannet; Christelle Gérard; Elizabeth Jarman; Gabor Jarai; Agnès Feige; Thomas Suply; Arthur Micard; Andrew Dunbar; Bruno Tigani; Nicolau Beckmann
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

9.  Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.

Authors:  Reid A Roberts; Tammy Shen; Irving C Allen; Warefta Hasan; Joseph M DeSimone; Jenny P Y Ting
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

10.  Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis.

Authors:  Irving C Allen; Erin McElvania-TeKippe; Justin E Wilson; John D Lich; Janelle C Arthur; Jonathan T Sullivan; Miriam Braunstein; Jenny P Y Ting
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more
  8 in total

1.  TIPS pentacene loaded PEO-PDLLA core-shell nanoparticles have similar cellular uptake dynamics in M1 and M2 macrophages and in corresponding in vivo microenvironments.

Authors:  Dylan K McDaniel; Ami Jo; Veronica M Ringel-Scaia; Sheryl Coutermarsh-Ott; Daniel E Rothschild; Michael D Powell; Rui Zhang; Timothy E Long; Kenneth J Oestreich; Judy S Riffle; Richey M Davis; Irving C Allen
Journal:  Nanomedicine       Date:  2016-12-29       Impact factor: 5.307

2.  lincRNA-Cox2 Functions to Regulate Inflammation in Alveolar Macrophages during Acute Lung Injury.

Authors:  Elektra Kantzari Robinson; Atesh Worthington; Donna Poscablo; Barbara Shapleigh; Mays Mohammed Salih; Haley Halasz; Lucas Seninge; Benny Mosqueira; Valeriya Smaliy; E Camilla Forsberg; Susan Carpenter
Journal:  J Immunol       Date:  2022-04-01       Impact factor: 5.426

3.  Machine learning identifies molecular regulators and therapeutics for targeting SARS-CoV2-induced cytokine release.

Authors:  Marina Chan; Siddharth Vijay; John McNevin; M Juliana McElrath; Eric C Holland; Taranjit S Gujral
Journal:  Mol Syst Biol       Date:  2021-09       Impact factor: 13.068

4.  Evaluating UiO-66 Metal-Organic Framework Nanoparticles as Acid-Sensitive Carriers for Pulmonary Drug Delivery Applications.

Authors:  Bader M Jarai; Zachary Stillman; Lucas Attia; Gerald E Decker; Eric D Bloch; Catherine A Fromen
Journal:  ACS Appl Mater Interfaces       Date:  2020-08-20       Impact factor: 9.229

5.  Quantification of bronchoalveolar neutrophil extracellular traps and phagocytosis in murine pneumonia.

Authors:  Samir Gautam; Yannick Stahl; Grant M Young; Rebecca Howell; Avi J Cohen; Derek A Tsang; Tommy Martin; Lokesh Sharma; Charles S Dela Cruz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-12       Impact factor: 5.464

6.  Pulmonary Exposure to Magnéli Phase Titanium Suboxides Results in Significant Macrophage Abnormalities and Decreased Lung Function.

Authors:  Dylan K McDaniel; Veronica M Ringel-Scaia; Holly A Morrison; Sheryl Coutermarsh-Ott; McAlister Council-Troche; Jonathan W Angle; Justin B Perry; Grace Davis; Weinan Leng; Valerie Minarchick; Yi Yang; Bo Chen; Sky W Reece; David A Brown; Thomas E Cecere; Jared M Brown; Kymberly M Gowdy; Michael F Hochella; Irving C Allen
Journal:  Front Immunol       Date:  2019-11-28       Impact factor: 7.561

7.  Diesel exhaust impairs TREM2 to dysregulate neuroinflammation.

Authors:  Hendrik J Greve; Christen L Mumaw; Evan J Messenger; Prasada R S Kodavanti; Joyce L Royland; Urmila P Kodavanti; Michelle L Block
Journal:  J Neuroinflammation       Date:  2020-11-22       Impact factor: 8.322

8.  Cardiolipin-mediated PPARγ S112 phosphorylation impairs IL-10 production and inflammation resolution during bacterial pneumonia.

Authors:  Mayank Garg; Saumya Johri; Shakti Sagar; Aniruddha Mundhada; Anurag Agrawal; Prabir Ray; Krishnendu Chakraborty
Journal:  Cell Rep       Date:  2021-02-09       Impact factor: 9.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.